Research & Development
Policy & Regulation
Trends & Finance
Product Launch: Page 3
Bio-Techne, Progen introduce new series of viral titer assays
The assays -- AAV1, AAV6, and AAV8 -- feature Progen’s antibody reagents, perform similarly to Progen’s AAV enzyme-linked immunoassays (ELISAs), and are part of the Ella immunoassay platform, Bio-Techne said.
October 11, 2022
Companies announce new products ahead of AACC 2022
Among them, OraSure Technologies said that its Omnigene Gut DNA and RNA product is available to gut microbiome researchers. The product, made by OraSure subsidiary DNA Genotek, allows for self-collection, stabilization, storage, and transportation of both microbial DNA and RNA at ambient temperature for gut microbiome profiling.
July 21, 2022
OraSure launches gut microbiome profiling product
OMR-205 allows for self-collection, stabilization, storage, and transportation of both microbial DNA and RNA at ambient temperature for gut microbiome profiling. It is made by OraSure's subsidiary DNA Genotek.
July 13, 2022
Hologic launches respiratory assays in Europe
Both products are compliant with the European In Vitro Diagnostic Medical Device Directive (IVDD) and are being made available in time for the Northern Hemisphere's respiratory viral season, the firm said.
July 10, 2022
BillionToOne launches liquid biopsy products for research
The products are available for research use in select academic cancer centers.
July 7, 2022
Thermo Fisher touts product launches at AACC 2021
For COVID-19, there are two polymerase chain reaction (PCR) tests: the Applied Biosystems TaqPath COVID-19 Fast PCR Combo Kit 2.0 and the Applied Biosystems TaqPath COVID-19 RNase P Combo Kit 2.0. The tests target eight genes across three regions of SARS-CoV-2.
September 28, 2021
Illumina, Merck partner on HRD test
Illumina will leverage its TruSight oncology (TSO) 500 content to develop a new HRD CDx test for the European Union and the U.K. to aid in the identification of ovarian cancer patients with positive HRD status who are eligible for treatment with Lynparza, an (ADP-ribose) polymerase inhibitor.
September 7, 2021
Thermo Fisher announces Q1 revenue increase
In the company's first quarter (end-April 3), revenue grew 59% to $9.9 billion, an increase over $6.2 billion in revenues reported in the first quarter of 2020.
April 28, 2021
VolitionRx highlights COVID-19 triage test clinical trial results
The studies, which were conducted at the University Hospital Liege in Belgium and the German Heart Center in Munich, aimed to confirm whether circulating nucleosomes could serve as a potential prognostic marker for COVID-19 disease severity. The researchers found that the company's Nu.Q epigenetics technology correlated with more severe COVID-19 cases, implying strong prognostic potential, according to VolitionRx.
July 14, 2020
Myriad launches self-sample kit for GeneSight pharmacogenomic test
The test involves a self-collected cheek swab, and while it is a direct-to-patient test, it still needs to be ordered by a healthcare provider. In launching the product, Myriad explained that the COVID-19 pandemic has increased the prevalence of mental health issues and has also driven demand for remote access to medical providers.
June 30, 2020
Crackdown on coronavirus antibody tests | Oncology shines in life after COVID-19 | Hepatic pathology case study
Dear LabPulse Member,
May 4, 2020
FDA takes action to counter novel coronavirus
The various efforts described by the FDA include sharing updates on processes to help product developers make medical countermeasures for the coronavirus, such as diagnostic tests, as rapidly as possible. The agency has also launched a webpage that provides key information for the public, including the FDA's efforts in response to the outbreak.
January 27, 2020
Page 3 of 4